| Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines RA Asherson, R Cervera, PG De Groot, D Erkan, MC Boffa, JC Piette, ... Lupus 12 (7), 530-534, 2003 | 1068 | 2003 |
| Diagnosis and management of the antiphospholipid syndrome D Garcia, D Erkan New England Journal of Medicine 378 (21), 2010-2021, 2018 | 811 | 2018 |
| Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th … G Ruiz-Irastorza, MJ Cuadrado, I Ruiz-Arruza, R Brey, M Crowther, ... Lupus 20 (2), 206-218, 2011 | 618 | 2011 |
| Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double‐blind, placebo‐controlled trial in asymptomatic antiphospholipid antibody … D Erkan, MJ Harrison, R Levy, M Peterson, M Petri, L Sammaritano, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 461 | 2007 |
| Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients S Bucciarelli, G Espinosa, R Cervera, D Erkan, JA Gómez‐Puerta, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 416* | 2006 |
| A cross‐sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome D Erkan, Y Yazici, MG Peterson, L Sammaritano, MD Lockshin Rheumatology 41 (8), 924-929, 2002 | 411 | 2002 |
| Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the … L Andreoli, CB Chighizola, A Banzato, GJ Pons‐Estel, GR de Jesus, ... Arthritis care & research 65 (11), 1869-1873, 2013 | 348 | 2013 |
| Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis KMJ Devreese, PG de Groot, B de Laat, D Erkan, EJ Favaloro, I Mackie, ... Journal of thrombosis and haemostasis 18 (11), 2828-2839, 2020 | 320 | 2020 |
| A pilot open‐label phase II trial of rituximab for non‐criteria manifestations of antiphospholipid syndrome D Erkan, JA Vega, G Ramón, E Kozora, MD Lockshin Arthritis & Rheumatism 65 (2), 464-471, 2013 | 288 | 2013 |
| 14th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... Autoimmunity reviews 13 (6), 685-696, 2014 | 285 | 2014 |
| Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry I Rodríguez-Pintó, M Moitinho, I Santacreu, Y Shoenfeld, D Erkan, ... Autoimmunity Reviews 15 (12), 1120-1124, 2016 | 282 | 2016 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 275 | 2023 |
| Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications JT Merrill, D Erkan, J Winakur, JA James Nature Reviews Rheumatology 16 (10), 581-589, 2020 | 272 | 2020 |
| Willis R1, Lockshin MD D Erkan, CL Aguiar, D Andrade, H Cohen, MJ Cuadrado, A Danowski, ... 14th International Congress on Antiphospholipid Antibodies: task force …, 2014 | 269 | 2014 |
| Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab H Berman, I Rodríguez-Pintó, R Cervera, N Morel, ... Autoimmunity Reviews 12 (11), 1085-1090, 2013 | 254 | 2013 |
| High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin D Erkan, JT Merrill, Y Yazici, L Sammaritano, JP Buyon, MD Lockshin Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 250 | 2001 |
| Catastrophic antiphospholipid syndrome: updated diagnostic algorithms D Erkan, G Espinosa, R Cervera Autoimmunity reviews 10 (2), 74-79, 2010 | 224 | 2010 |
| The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus O Ünlü, S Zuily, D Erkan European journal of rheumatology 3 (2), 75, 2016 | 216 | 2016 |
| Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis L Arnaud, A Mathian, A Ruffatti, D Erkan, M Tektonidou, R Cervera, ... Autoimmunity Reviews 13 (3), 281-291, 2014 | 205 | 2014 |
| Long term outcome of catastrophic antiphospholipid syndrome survivors D Erkan, RA Asherson, G Espinosa, R Cervera, J Font, JC Piette, ... Annals of the rheumatic diseases 62 (6), 530-533, 2003 | 191 | 2003 |
